Myocardial infarction (MI) is the leading cause of death among ischemic heart diseases and is associated with several long-term cardiovascular complications, such as angina, re-infarction, arrhythmias, and heart failure. However, MI is frequently accompanied by non-cardiovascular multiple comorbidities, including brain disorders such as stroke, anxiety, depression, and cognitive impairment. Accumulating experimental and clinical evidence suggests a causal relationship between MI and stroke, but the precise underlying mechanisms have not yet been elucidated. Indeed, the risk of stroke remains a current challenge in patients with MI, in spite of the improvement of medical treatment among this patient population has reduced the risk of stroke. In this review, the effects of the signaling from the ischemic heart to the brain, such as neuroinflammation, neuronal apoptosis, and neurogenesis, and the possible actors mediating these effects, such as systemic inflammation, immunoresponse, extracellular vesicles, and microRNAs, are discussed.

Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain / P. Gelosa, L. Castiglioni, J. Rzemieniec, M. Muluhie, M. Camera, L. Sironi. - In: JOURNAL OF MOLECULAR MEDICINE. - ISSN 0946-2716. - 100:1(2022 Jan), pp. 23-41. [10.1007/s00109-021-02154-3]

Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain

P. Gelosa
Primo
;
L. Castiglioni
Secondo
;
J. Rzemieniec;M. Muluhie;M. Camera
Penultimo
;
L. Sironi
Ultimo
2022

Abstract

Myocardial infarction (MI) is the leading cause of death among ischemic heart diseases and is associated with several long-term cardiovascular complications, such as angina, re-infarction, arrhythmias, and heart failure. However, MI is frequently accompanied by non-cardiovascular multiple comorbidities, including brain disorders such as stroke, anxiety, depression, and cognitive impairment. Accumulating experimental and clinical evidence suggests a causal relationship between MI and stroke, but the precise underlying mechanisms have not yet been elucidated. Indeed, the risk of stroke remains a current challenge in patients with MI, in spite of the improvement of medical treatment among this patient population has reduced the risk of stroke. In this review, the effects of the signaling from the ischemic heart to the brain, such as neuroinflammation, neuronal apoptosis, and neurogenesis, and the possible actors mediating these effects, such as systemic inflammation, immunoresponse, extracellular vesicles, and microRNAs, are discussed.
EVs; miRNAs; myocardial infarct; neuroinflammation; stroke
Settore BIO/14 - Farmacologia
gen-2022
21-ott-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
Gelosa_2021_Article_J_Mol_Med.pdf

accesso aperto

Descrizione: online first
Tipologia: Publisher's version/PDF
Dimensione 2.03 MB
Formato Adobe PDF
2.03 MB Adobe PDF Visualizza/Apri
s00109-021-02154-3.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.27 MB
Formato Adobe PDF
2.27 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/881882
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 6
social impact